Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nodules are localized, often spherical anatomical or pathological structures that form within various tissues and organs. In clinical medicine, they are most commonly identified as lung, thyroid, or rheumatoid nodules and can be benign (inflammatory) or malignant (cancerous) [20, 23]. While 'nodules' are not specific molecular targets themselves, they serve as critical diagnostic and therapeutic endpoints; for example, the regression of rheumatoid nodules is a key indicator of efficacy for Janus kinase (JAK) inhibitors such as tofacitinib [4]. In oncology, the detection and molecular profiling of nodules (e.g., identifying BRAF or RET mutations in thyroid nodules) guide the administration of targeted tyrosine kinase inhibitors [1, 3]. In plant biology, root nodules are specialized organs formed through symbiotic interactions with nitrogen-fixing bacteria, involving specific signaling molecules called nodulins and nodulation receptor kinases [10, 11, 13]. Because the term describes a macroscopic or microscopic structure rather than a discrete protein or receptor, it is not considered a molecular therapeutic target in the traditional sense [1, 23].
Nodules are physical structures and not molecular targets; however, drugs targeting molecules within them (e.g., kinases or cytokines) can lead to nodule regression or are used for targeted imaging [4, 8, 12].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nodules.